ScholarLens Back to search
2021•AmyloidRequires access

Factors associated with changes in serum transthyretin after treatment with tafamidis and outcomes in transthyretin cardiac amyloidosis

Sunil E. Saith, Danilo Gamino, Sergio L. Teruya, Samantha Guadalupe, Stephen T. Helmke, Jeffeny De Los Santos, Jeff Goldsmith, Hannah Rosenblum, Jan M. Griffin, Mathew S. Maurer

Open publisher page 10 citations

Abstract

"Factors associated with changes in serum transthyretin after treatment with tafamidis and outcomes in transthyretin cardiac amyloidosis." Amyloid, 28(4), pp. 267–268

About this research paper

What this paper is about

"Factors associated with changes in serum transthyretin after treatment with tafamidis and outcomes in transthyretin cardiac amyloidosis." Amyloid, 28(4), pp. 267–268

Why it matters

OpenAlex reports 10 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

"Factors associated with changes in serum transthyretin after treatment with tafamidis and outcomes in transthyretin cardiac amyloidosis." Amyloid, 28(4), pp. 267–268

Key concepts: Transthyretin, Amyloidosis, Medicine, Cardiac amyloidosis, Amyloid (mycology), Amyloid fibril, Internal medicine, Endocrinology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Factors associated with changes in serum transthyretin after treatment with tafamidis and outcomes in transthyretin cardiac amyloidosis — Research Paper | ScholarLens